Journal
/
/
A “Plug-And-Display” Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
JoVE Journal
Bioengineering
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Bioengineering
A “Plug-And-Display” Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
DOI:

08:07 min

July 25, 2022

, , , , , ,

Chapters

  • 00:05Introduction
  • 00:44OMV-SC Preparation
  • 03:02RBD-ST Preparation
  • 05:22OMV-RBD Bioconjugation and Purification
  • 06:39Results: OMV-RBD Verification, Particle Size Distribution, and Visualization by TEM
  • 07:42Conclusion

Summary

Automatic Translation

The present protocol describes the bioengineering of outer membrane vesicles to be a "Plug-and-Display" vaccine platform, including production, purification, bioconjugation, and characterization.

Related Videos

Read Article